Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × Dasatinib × Clear all

NCT00459108 2018-04-19

Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery

Phase 2 Terminated

25 enrolled 7 charts

Gastrointestinal

Carcinoma, Hepatocellular